Table II.
Groupa | Average lung lesion score | Frequency of affected lungsb (%) | Frequency of DNA detectionc (%) | Average adjusted optical density of antibodiesd |
---|---|---|---|---|
1 | 12.56 | 83.0 | 100 | 0.685 |
2 | 1.30 | 53.3 | 79.3 | 0.216 |
3 | 5.70 | 74.0 | 100 | 0.623 |
4 | 4.45 | 70.0 | 100 | 0.563 |
5 | 5.51 | 81.5 | 100 | 0.476 |
6 | 1.07 | 39.3 | 10.7 | 0.122 |
7 | 4.27 | 55.2 | 100 | 0.443 |
8 | 7.36 | 80.0 | 100 | 0.444 |
9 | 3.04 | 52.0 | 86.2 | 0.390 |
10 | 8.06 | 86.6 | 100 | 0.284 |
11 | 7.30 | 80.0 | 71.8 | 0.940 |
12 | 2.38 | 44.0 | 15.0 | 0.192 |
15 | 1.15 | 34.4 | 25.0 | 0.117 |
16 | 7.06 | 63.3 | 48.3 | 0.442 |
17 | 0 | 0 | 35.7 | 0.427 |
18 | 0.23 | 6.6 | 33.3 | 0.275 |
19 | 1.06 | 18.8 | 46.0 | 0.229 |
20 | 1.81 | 40.1 | 40.9 | 0.232 |
Mean | 4.12 | 53.5 | 66.2 | 0.394 |
Standard error | 0.80 | 6.3 | 8.0 | 0.050 |
Groups 13 and 14 were eliminated from the study for marketing reasons.
Lungs with lesions associated with M. hyopneumoniae infection.
In bronchial swabs by nested polymerase chain reaction.
In an enzyme-linked immunosorbent assay, a value of 0.24 being considered evidence of seroconversion.